tabula rasa announc acquisit prescribewel
ev/rev cash prescribewel provid engag rx network
solut connect pharmacist patient payor prescribewel
relationship pharmaci pharmacist acquisit
provid leverag push solut pharmaci expand
prescribewellnesss relationship push compani solut management note
visibl cross sell solut potenti open new rfp
inaccess combin acquisit add high margin servic
revenu number expect growth rang reiter outperform
rate adjust target
transact detail paid cash revenu
prescribewel pw provid medic adher care servic
 med synch immun commun pharmaci pw revenue/ebitda
see top-line grow
pw found ceo al babbington join acquisit
vs prior estim consensu
net loss re-affirmed vs consensu
adj ebitda revis vs
consensu revenu guid
pw scale partner technolog pw commun pharmaci
client locat within five mile peopl popul
activ patient partner includ top ai use pharmaci
data target patient vaccin appoint find best medicar plan
estim
increas estim
prescribewel acquisit contribut
also adjust estim chang mix product servic
revenu show higher product revenu growth
adj ebitda estim increas
adjust target keep valuat
methodolog intact decreas multipl one turn due potenti risk
associ increas number acquisit past month
price target still leav plenti upsid potenti expect compani
lead way mrm mtm segment
year price histori
proprietari
reduc
technolog servic
medic safeti patient outcom
lower healthcar cost client
analyst certif import disclosur see disclosur
tabula rasa proprietari medic risk therapi solut
enabl signific shift care elderli
pace program all-inclus elderli
elimin advers drug event deal complex
multiple-med regimen home demograph tailwind
increas use multipl medic cost focu
drive penetr non-profit for-profit pace
program trhc solut mtm mrm
solut signific relev commerci health plan
see wave adopt sinfoniarx acquisit
acceler growth
continu growth sustain oper margin improv
contract new pace organ
new commerci contract emtm enhanc medic therapi
manag medwis solut
mix new live tilt commerci live penetr
new market entrant pose headlin risk potenti take
regulatori chang disrupt pace adopt
adjust target keep valuat methodolog intact decreas multipl one turn due potenti
risk associ increas number acquisit past month price target still leav plenti upsid current
level expect compani lead way mrm mtm segment
regulatori turmoil disrupt pace could impact growth increas attent mtm could attract competit
transact detail paid cash rev prescribewel pw
provid medic adher care servic med synch immun commun
pharmaci pw revs/ebitda see top-line grow
pw found ceo al babbington join acquisit close
guid ise revis revenue guid vs prior
estim consensu net loss re-affirmed vs estim consensu
adj ebitda re-affirmed vs estim consensu
ebitda guid ise revis revenue guid
vs prior estim consensu net loss re-affirmed vs
consensu adj ebitda revis vs consensu
pw scale partner technolog pw commun pharmaci client locat within
mile peopl popul activ patient partner includ
top ai use pharmaci data target patient vaccin appoint find best medicar
subscript model pw primarili subscript model contract annual monthli
licens base number app size pharmaci without much season retent rate
rooftop rev gm near histor adj ebitda margin near trhc target
scale base pipelin recur rev see pw top-line growth year
multipl opportun see opportun payer pharmaci drive outcom caregiv
mostli age live near/far parent understand via risk score use local pharmacist
mitig prevent issu rfp commun pharmaci network help sinfonia central
call center analyt pw includ major emr payer pbm state vaccin registri de-
identifi data lake ai-ml product develop
research develop
sale market
gener administr
depreci amort
total expens
incom tax
dilut prefer stock warrant
compani report oppenheim estim
stock price compani mention report
